Matches in Wikidata for { <http://www.wikidata.org/entity/Q58447633> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q58447633 description "article" @default.
- Q58447633 description "im Mai 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58447633 description "wetenschappelijk artikel" @default.
- Q58447633 description "наукова стаття, опублікована в травні 2014" @default.
- Q58447633 name "Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals" @default.
- Q58447633 name "Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals" @default.
- Q58447633 type Item @default.
- Q58447633 label "Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals" @default.
- Q58447633 label "Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals" @default.
- Q58447633 prefLabel "Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals" @default.
- Q58447633 prefLabel "Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals" @default.
- Q58447633 P1433 Q58447633-7A559D3F-0D07-473D-B30C-1EFDDDDEB1F4 @default.
- Q58447633 P1476 Q58447633-B95AF961-9BDB-4D48-B64A-64ACED52ECC8 @default.
- Q58447633 P2093 Q58447633-C44E188C-24A7-4B45-9A73-6C5F02516E0E @default.
- Q58447633 P2860 Q58447633-0ABD5122-4F7B-4B67-BD3E-F90E092D1220 @default.
- Q58447633 P2860 Q58447633-0EAF6E7A-7FF9-438A-914B-0043C34816A2 @default.
- Q58447633 P2860 Q58447633-1DEB1CB9-C1F1-4E49-8CB6-8F5634306086 @default.
- Q58447633 P2860 Q58447633-3A8EF11B-3605-456D-AE09-C6F9B076E0C8 @default.
- Q58447633 P2860 Q58447633-6CAAA564-545A-4056-A325-C4261D248F91 @default.
- Q58447633 P2860 Q58447633-8786CBFC-9F9F-4926-AE89-6FDC7BCCA570 @default.
- Q58447633 P2860 Q58447633-AAECDE3A-2829-4277-BC38-B539F0A8204A @default.
- Q58447633 P2860 Q58447633-B695F587-BE20-42F4-A959-8EE60DA71A94 @default.
- Q58447633 P2860 Q58447633-B7431AF9-92DF-4C6D-B449-53801E5F8097 @default.
- Q58447633 P2860 Q58447633-C131892F-CD52-4809-93F3-2572446FC93E @default.
- Q58447633 P2860 Q58447633-D1D02562-E29C-41DD-B455-CDA24569732C @default.
- Q58447633 P2888 Q58447633-A4F9A142-F7C6-4BBE-B713-7C1C559012D2 @default.
- Q58447633 P304 Q58447633-342126E6-9AC1-49C2-8FDE-61C5A1CB7499 @default.
- Q58447633 P31 Q58447633-F002F258-57B9-4A22-BD79-A7CBF4D2A78A @default.
- Q58447633 P356 Q58447633-739D0A31-DD59-4C95-8180-3DDF62C488F2 @default.
- Q58447633 P433 Q58447633-50D8FB7A-A1DB-4A11-895F-2CC56FF59D15 @default.
- Q58447633 P478 Q58447633-AF1ADAF9-1DF6-4687-8740-C8FF950984FD @default.
- Q58447633 P50 Q58447633-4AACC38C-68DE-4F2C-8944-4672CB0358DD @default.
- Q58447633 P50 Q58447633-51D28847-654A-4052-8A84-0B2D90091BCB @default.
- Q58447633 P50 Q58447633-DB2BF604-BE8B-4AB6-970A-42A0B6B434A8 @default.
- Q58447633 P50 Q58447633-E618F58F-9DB4-4A8A-98A5-EFDE07BAA794 @default.
- Q58447633 P577 Q58447633-916E382D-D669-4277-B431-6DD7514730C2 @default.
- Q58447633 P698 Q58447633-3C86FD51-7F4B-482D-8694-AF71E96E3B37 @default.
- Q58447633 P921 Q58447633-0342b29a-5cac-4b12-a3c6-61a5994059a5 @default.
- Q58447633 P921 Q58447633-66F89760-CC99-4EA1-A026-F67F2CAD7EE5 @default.
- Q58447633 P921 Q58447633-A9A6E9B9-49A0-4F6D-94F9-961AB3752D7A @default.
- Q58447633 P356 S00125-014-3264-2 @default.
- Q58447633 P698 24879388 @default.
- Q58447633 P1433 Q5270140 @default.
- Q58447633 P1476 "Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals" @default.
- Q58447633 P2093 "Tina Vilsbøll" @default.
- Q58447633 P2860 Q34649087 @default.
- Q58447633 P2860 Q37193717 @default.
- Q58447633 P2860 Q39221120 @default.
- Q58447633 P2860 Q39314896 @default.
- Q58447633 P2860 Q44216727 @default.
- Q58447633 P2860 Q51381300 @default.
- Q58447633 P2860 Q53262617 @default.
- Q58447633 P2860 Q58168509 @default.
- Q58447633 P2860 Q58448416 @default.
- Q58447633 P2860 Q58449447 @default.
- Q58447633 P2860 Q73840581 @default.
- Q58447633 P2888 s00125-014-3264-2 @default.
- Q58447633 P304 "1720-1725" @default.
- Q58447633 P31 Q13442814 @default.
- Q58447633 P356 "10.1007/S00125-014-3264-2" @default.
- Q58447633 P433 "8" @default.
- Q58447633 P478 "57" @default.
- Q58447633 P50 Q28373106 @default.
- Q58447633 P50 Q58110286 @default.
- Q58447633 P50 Q58915294 @default.
- Q58447633 P50 Q59659637 @default.
- Q58447633 P577 "2014-05-31T00:00:00Z" @default.
- Q58447633 P698 "24879388" @default.
- Q58447633 P921 Q28163629 @default.
- Q58447633 P921 Q3025883 @default.
- Q58447633 P921 Q37525 @default.